Established in 2010, the MRFBC is a national network of 30 centers of excellence in melanoma that collaborate to accelerate the research and development of the most promising therapies in melanoma treatment in order to deliver curative options to patients. The Consortium institutions have a demonstrated track record of receiving NIH/peer-reviewed funding for multidisciplinary research in melanoma, publications in major medical journals, presentations at the major cancer and melanoma meetings, clinical trial expertise and patient care.

This year's meeting will highlight exciting research updates from MRFBC members, including those from newly joined institutions. The meeting will also feature translational studies and collaboration opportunities presented by industry partners.